ImStar Therapeutics is a biotechnology company developing treatments for neurodegenerative diseases. The company is headquartered in Vancouver, British Columbia, Canada and was founded in 2012 by Daniel Wattier and Jean Pierre Julien, Professor and Senior Canada Research Chair at Université Laval. ImStar Therapeutics is developing treatments for neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Dementia, Alzheimer's Disease, and Parkinson's Disease.
The company is using its unique research findings and understanding of a protein called TAR DNA-binding protein 43 (TDP-43) and its role in inflammatory responses to develop novel treatments for neurodegenerative diseases. The ALS therapeutic target TDP-43, also called TANA (TDP-43 Associated NF-κB Activation) is based on the research of Dr. Julien at Université Laval.
IMS-088 was considered their lead drug development program in 2016. The compound was designed to target a key immune system activation pathway involved in neurodegeneration. IMS-088 was derived from withaferin A, a natural compound isolated from the leaves of the winter cherry plant Withania somnifera. Withaferin A in preclinical studies showed improvements in function and extended survival but lacked certain characteristics that would make it optimal for drug development. The compound IMS-088 was designed by ImStar chemists to have improved drug-like properties and to be potent and safe in preclinical studies.
On June 8, 2016 ImStar Therapeutics closed their seed funding round with $1.8 million in funding from BDC Venture Capital and Accel-Rx Health Sciences Accelerator.
ImStar Therapeutics was founded by Daniel Wattier.
Co-Founder & CEO
Senior Vice President, Research and Development
Jean Pierre Julien
Co-Founder & CSO
ImStar Therapeutics raises $1.8 million to research ALS treatment solutions | BetaKit
ImStar Therapeutics Selects Lead Drug Candidate for ALS
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
Documentaries, videos and podcasts
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.